Tokyo, Japan

Yuki Tochigi

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Kaneka Corporation. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuki Tochigi. Retrieved from https://idiyas.com/inventor/yuki-tochigi-c6taqj6a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yuki Tochigi: Innovator in Renal Health Solutions

Introduction

Yuki Tochigi is a notable inventor based in Tokyo, Japan. She has made significant contributions to the field of renal health through her innovative research and patenting efforts. Her work focuses on methods to improve kidney function, particularly in non-human animals.

Latest Patents

Yuki Tochigi holds a patent for a method aimed at inhibiting renal hypofunction in non-human animals. This method involves administering cat-derived erythropoietin to animals suffering from renal hypofunction, which may be caused by chronic kidney disease. The administration of this treatment can occur repeatedly at intervals of 7 to 30 days, showcasing a novel approach to managing kidney health.

Career Highlights

Tochigi is associated with Kaneka Corporation, where she continues to develop her research and innovations. Her work has the potential to impact veterinary medicine and animal health significantly.

Collaborations

Yuki collaborates with esteemed colleagues, including Hirokazu Sakamoto and Hiroetsu Suzuki, to further her research and enhance the effectiveness of her inventions.

Conclusion

Yuki Tochigi's contributions to renal health through her innovative patent demonstrate her commitment to advancing medical science. Her work not only benefits non-human animals but also paves the way for future research in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…